biguanides has been researched along with fibrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gormsen, J | 1 |
| Knafl, D; Thalhammer, F; Vossen, MG | 1 |
2 other study(ies) available for biguanides and fibrin
| Article | Year |
|---|---|
Fibrinolytic activity and haemagglutination inhibition immunoassays.
Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemagglutination Inhibition Tests; Hemostasis; Humans; Immunoassay; Immunodiffusion; Immunoelectrophoresis; Liver Cirrhosis; Male; Metformin; Middle Aged; Neoplasm Metastasis; Nicotinic Acids; Physical Exertion; Plasminogen; Prostatic Neoplasms; Stimulation, Chemical; Time Factors; Tolazamide | 1970 |
In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin-layer (PRF)-a laboratory evaluation of a modern, autologous wound treatment.
Topics: Agar; Amikacin; Anti-Bacterial Agents; Bandages; Biguanides; Delayed-Action Preparations; Disk Diffusion Antimicrobial Tests; Drug Liberation; Fibrin; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Models, Biological; Platelet-Derived Growth Factor; Platelet-Rich Plasma; Pseudomonas aeruginosa; Teicoplanin; Wound Healing | 2017 |